A new study performed for the biotechnology company Aker BioMarine has demonstrated that Superba™ Krill Oil might be of benefit in individuals with metabolic syndrome and fatty liver. These results are important because they confirm previous findings.
In the pre-clinical study, feeding mice a high-fat diet led to a significant increase in the amount of fat and cholesterol in the liver. A control group was fed a low-fat diet. The food supplement Superba™ Krill Oil, which is rich in omega-3 phospholipids, significantly reduced fat and cholesterol in the liver of mice fed the high-fat diet.
It is significant that Superba™ Krill Oil had a beneficial effect on fatty liver and cholesterol in our experimental animals, said Dr. Jeffrey Cohn. He was leader of the study that was performed by the internationally acknowledged research group in Australia.
Moreover, the results showed that Superba™ Krill Oil reduced the level of cholesterol in the blood. Mice fed the high-fat diet had a 65% increase in cholesterol level relative to mice fed the low-fat diet. Addition of Superba™ Krill Oil decreased the amount of cholesterol to a ”normal level” in mice fed the high-fat diet.
Aker BioMarine has in this study documented the effects of Superba™ Krill Oil in cooperation with a leading research team in the scientific field. This study confirms previous findings published in June 2009, and shows that Superba™ Krill Oil might have beneficial effects in persons with metabolic syndrome and that Superba™ Krill Oil might have beneficial effects on the cholesterol level, says M.D. Hogne Vik, EVP, Documentation, Aker BioMarine.
The study is published in Journal of Agricultural and Food Chemistry and is available online at http://pubs.acs.org/doi/abs/10.1021/jf9016042.